HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinicopathologic correlation of serum tissue polypeptide specific antigen in hepatocellular carcinoma.

AbstractOBJECTIVE:
Recently, tissue polypeptide specific antigen (TPS) has been introduced as a cell proliferation marker. Little is known about its clinical significance in hepatocellular carcinoma (HCC). This study aimed to clarify serum TPS levels and tumor invasiveness of HCC.
METHODS:
Serum TPS levels were determined with a monoclonal TPS IRMA assay in 69 patients with HCC. A correlation between serum TPS levels and clinical, biochemical, and pathological features was sought and compared with that of alpha-fetoprotein (AFP). In 57 healthy subjects, 56 patients with biopsy-proven chronic hepatitis and in 49 patients with liver cirrhosis, serum TPS levels were assayed and compared.
RESULTS:
Serum TPS levels were significantly correlated with glutamic oxalacetic transaminase (p < 0.0001), glutamic pyruvic transaminase (p < 0.001), and lactate dehydrogenase (p = 0.027). There tended to be a positive relationship between serum TPS levels and tumor size, histological differentiation, capsular invasion, portal invasion, and clinical staging, although it did not reach statistical significance. A significant correlation, however, was observed between AFP and tumor size (p = 0.01), number (p = 0.042), histological grading (p = 0.028), portal invasion (p = 0.009), and clinical staging (p = 0.03). Patients with HCC had significantly higher TPS than healthy subjects (p < 0.001). However, there was substantial overlap between patients with HCC, chronic hepatitis, and liver cirrhosis.
CONCLUSIONS:
Our data suggest that serum TPS is not significantly related to tumor invasiveness in patients with HCC. Serum TPS levels are affected by the proliferative activity of the underlying chronic liver disease, which is frequently associated with HCC in Chinese patients. As a cell proliferation marker, serum TPS should be interpreted cautiously in the presence of chronic liver disease.
AuthorsW J Yao, T T Chang, S T Wang, N H Chow, P W Lin, Y C Chang, D G Tu, N T Chiu
JournalOncology (Oncology) Vol. 61 Issue 1 Pg. 64-70 ( 2001) ISSN: 0030-2414 [Print] Switzerland
PMID11474251 (Publication Type: Journal Article)
CopyrightCopyright 2001 S. Karger AG, Basel
Chemical References
  • Biomarkers, Tumor
  • Peptides
  • alpha-Fetoproteins
  • tissue polypeptide specific antigen
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Asian People
  • Biomarkers, Tumor (blood)
  • Carcinoma, Hepatocellular (immunology, pathology)
  • Female
  • Humans
  • Liver Diseases (immunology, pathology)
  • Liver Neoplasms (immunology, pathology)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Peptides (blood)
  • Predictive Value of Tests
  • Prognosis
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: